カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界のアルツハイマー病治療薬市場2022年～2026年

■ 英語タイトル：Global Alzheimers Disease Therapeutics Market 2022-2026

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR40742-22）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR40742-22
■ 発行日：2022年4月21日
■ 調査対象地域：北米、ヨーロッパ、アジア、その他地域
■ 産業分野：医薬品
■ ページ数：約120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥456,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のアルツハイマー病治療薬市場2022年～2026年]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

テクナビオ社は、世界のアルツハイマー病治療薬市場規模が2022年から2026年まで年平均8.76％成長し、39.9億ドルに達すると予測しています。本調査レポートでは、アルツハイマー病治療薬の世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、薬剤分類別（コリンエステラーゼ阻害剤、N-メチル-D-アスパラギン酸受容体拮抗薬、その他）分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析など、以下の内容を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のアルツハイマー病治療薬市場規模：薬剤分類別（コリンエステラーゼ阻害剤、N-メチル-D-アスパラギン酸受容体拮抗薬、その他）
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析

Global Alzheimers Disease Therapeutics Market 2022-2026

Technavio has been monitoring the Alzheimers disease therapeutics market and it is poised to grow by $ 3.99 bn during 2022-2026, accelerating at a CAGR of 8.76% during the forecast period. Our report on the Alzheimers disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the availability, research, and development of novel biomarkers, increasing awareness of Alzheimer’s disease, and a strong pipeline coupled with the approval of therapeutics.

The Alzheimers disease therapeutics market analysis includes geography
Technavio’s Alzheimers disease therapeutics market is segmented as below:

By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the emergence of regenerative therapies as one of the prime reasons driving the Alzheimers disease therapeutics market growth during the next few years. Also, increasing funding for therapeutics discovery and an increase in strategic collaborations will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on Alzheimers disease therapeutics market covers the following areas:
• Alzheimers disease therapeutics market sizing
• Alzheimers disease therapeutics market forecast
• Alzheimers disease therapeutics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Alzheimer’s disease therapeutics market vendors that include AB Science SA, AbbVie Inc., AgeneBio Inc., Aurobindo Pharma Ltd., Biogen Inc., Denali Therapeutics Inc., Eisai Co. Ltd., Eli Lilly, and Co., Grifols SA, H Lundbeck AS, Johnson and Johnson, Lupin Ltd., Neuronascent Inc., Novartis AG, Shanghai Green Valley Pharmaceuticals Co. Ltd., Spinogenix Inc., T3D Therapeutics Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Vivoryon Therapeutics AG. Also, the Alzheimers disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/alzheimers-disease-therapeutics-market-industry-size-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Drug Class
o 5.1 Market segments
o Exhibit 24: Chart on Drug Class – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Drug Class – Market share 2021-2026 (%)
o 5.2 Comparison by Drug Class
o Exhibit 26: Chart on Comparison by Drug Class
o Exhibit 27: Data Table on Comparison by Drug Class
o 5.3 Cholinesterase inhibitors – Market size and forecast 2021-2026
o Exhibit 28: Chart on Cholinesterase inhibitors – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Cholinesterase inhibitors – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Cholinesterase inhibitors – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Cholinesterase inhibitors – Year-over-year growth 2021-2026 (%)
o 5.4 N-methyl-D-aspartate receptor antagonist – Market size and forecast 2021-2026
o Exhibit 32: Chart on N-methyl-D-aspartate receptor antagonist – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on N-methyl-D-aspartate receptor antagonist – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on N-methyl-D-aspartate receptor antagonist – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on N-methyl-D-aspartate receptor antagonist – Year-over-year growth 2021-2026 (%)
o 5.5 Other drug class – Market size and forecast 2021-2026
o Exhibit 36: Chart on Other drug class – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Other drug class – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Other drug class – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Other drug class – Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Drug Class
o Exhibit 40: Market opportunity by Drug Class ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share by geography 2021-2026 (%)
o Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Canada – Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.9 UK – Market size and forecast 2021-2026
o Exhibit 70: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.10 Germany – Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.11 Japan – Market size and forecast 2021-2026
o Exhibit 78: Chart on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Japan – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Japan – Year-over-year growth 2021-2026 (%)
o 7.12 China – Market size and forecast 2021-2026
o Exhibit 82: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity by geography
o Exhibit 86: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 93: AbbVie Inc. – Overview
o Exhibit 94: AbbVie Inc. – Product / Service
o Exhibit 95: AbbVie Inc. – Key offerings
o 10.4 Aurobindo Pharma Ltd.
o Exhibit 96: Aurobindo Pharma Ltd. – Overview
o Exhibit 97: Aurobindo Pharma Ltd. – Product / Service
o Exhibit 98: Aurobindo Pharma Ltd. – Key offerings
o 10.5 Eisai Co. Ltd.
o Exhibit 99: Eisai Co. Ltd. – Overview
o Exhibit 100: Eisai Co. Ltd. – Business segments
o Exhibit 101: Eisai Co. Ltd. – Key offerings
o Exhibit 102: Eisai Co. Ltd. – Segment focus
o 10.6 Eli Lilly and Co.
o Exhibit 103: Eli Lilly and Co. – Overview
o Exhibit 104: Eli Lilly and Co. – Product / Service
o Exhibit 105: Eli Lilly and Co. – Key offerings
o 10.7 H Lundbeck AS
o Exhibit 106: H Lundbeck AS – Overview
o Exhibit 107: H Lundbeck AS – Product / Service
o Exhibit 108: H Lundbeck AS – Key offerings
o 10.8 Johnson and Johnson
o Exhibit 109: Johnson and Johnson – Overview
o Exhibit 110: Johnson and Johnson – Business segments
o Exhibit 111: Johnson and Johnson – Key news
o Exhibit 112: Johnson and Johnson – Key offerings
o Exhibit 113: Johnson and Johnson – Segment focus
o 10.9 Lupin Ltd.
o Exhibit 114: Lupin Ltd. – Overview
o Exhibit 115: Lupin Ltd. – Product / Service
o Exhibit 116: Lupin Ltd. – Key news
o Exhibit 117: Lupin Ltd. – Key offerings
o 10.10 Novartis AG
o Exhibit 118: Novartis AG – Overview
o Exhibit 119: Novartis AG – Business segments
o Exhibit 120: Novartis AG – Key offerings
o Exhibit 121: Novartis AG – Segment focus
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 122: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 123: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 124: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 125: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 126: Teva Pharmaceutical Industries Ltd. – Segment focus
o 10.12 Viatris Inc.
o Exhibit 127: Viatris Inc. – Overview
o Exhibit 128: Viatris Inc. – Business segments
o Exhibit 129: Viatris Inc. – Key offerings
o Exhibit 130: Viatris Inc. – Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 131: Inclusions checklist
o Exhibit 132: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 133: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 134: Research methodology
o Exhibit 135: Validation techniques employed for market sizing
o Exhibit 136: Information sources
o 11.5 List of abbreviations
o Exhibit 137: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Drug Class – Market share 2021-2026 (%)
Exhibits25: Data Table on Drug Class – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Drug Class
Exhibits27: Data Table on Comparison by Drug Class
Exhibits28: Chart on Cholinesterase inhibitors – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Cholinesterase inhibitors – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Cholinesterase inhibitors – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Cholinesterase inhibitors – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on N-methyl-D-aspartate receptor antagonist – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on N-methyl-D-aspartate receptor antagonist – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on N-methyl-D-aspartate receptor antagonist – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on N-methyl-D-aspartate receptor antagonist – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Other drug class – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Other drug class – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Other drug class – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Other drug class – Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Drug Class ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share by geography 2021-2026 (%)
Exhibits43: Data Table on Market share by geography 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Japan – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Japan – Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity by geography ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: AbbVie Inc. – Overview
Exhibits94: AbbVie Inc. – Product / Service
Exhibits95: AbbVie Inc. – Key offerings
Exhibits96: Aurobindo Pharma Ltd. – Overview
Exhibits97: Aurobindo Pharma Ltd. – Product / Service
Exhibits98: Aurobindo Pharma Ltd. – Key offerings
Exhibits99: Eisai Co. Ltd. – Overview
Exhibits100: Eisai Co. Ltd. – Business segments
Exhibits101: Eisai Co. Ltd. – Key offerings
Exhibits102: Eisai Co. Ltd. – Segment focus
Exhibits103: Eli Lilly and Co. – Overview
Exhibits104: Eli Lilly and Co. – Product / Service
Exhibits105: Eli Lilly and Co. – Key offerings
Exhibits106: H Lundbeck AS – Overview
Exhibits107: H Lundbeck AS – Product / Service
Exhibits108: H Lundbeck AS – Key offerings
Exhibits109: Johnson and Johnson – Overview
Exhibits110: Johnson and Johnson – Business segments
Exhibits111: Johnson and Johnson – Key news
Exhibits112: Johnson and Johnson – Key offerings
Exhibits113: Johnson and Johnson – Segment focus
Exhibits114: Lupin Ltd. – Overview
Exhibits115: Lupin Ltd. – Product / Service
Exhibits116: Lupin Ltd. – Key news
Exhibits117: Lupin Ltd. – Key offerings
Exhibits118: Novartis AG – Overview
Exhibits119: Novartis AG – Business segments
Exhibits120: Novartis AG – Key offerings
Exhibits121: Novartis AG – Segment focus
Exhibits122: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits123: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits124: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits125: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits126: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits127: Viatris Inc. – Overview
Exhibits128: Viatris Inc. – Business segments
Exhibits129: Viatris Inc. – Key offerings
Exhibits130: Viatris Inc. – Segment focus
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Validation techniques employed for market sizing
Exhibits136: Information sources
Exhibits137: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の民間航空機用シート内電源システム市場2022年～2026年
  • 世界の皮膚科用医薬品市場2022年～2026年
  • 世界の乳房用組織拡張器市場2022年～2026年
  • 世界の顔面インプラント市場2022年～2026年
  • 世界の天然痘治療市場2022年～2026年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR40742-22 )"世界のアルツハイマー病治療薬市場2022年～2026年" (英文：Global Alzheimers Disease Therapeutics Market 2022-2026)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。